No Prescription |
 |
 | ||
|
Vitamax Fish Oil |
|
| ||
No Prescription » Prescription Drugs 17 » Vitamax Fish Oil Helping to: reduce arthritic swelling maintain a healthy cardiovascular system assist in the maintenance of normal eye and brain function reduce inflammation and joint swelling associated with arthritis and decrease fat in the blood (triglycerides) in healthy people. How it worksOmega 3 found in fish oil acts as an anti-inflammatory agent. Medical research shows that consumption of Omega 3 essential fatty acids comprising of DHA and EPA can help maintain healthy cholesterol levels in healthy individuals. Fish Oil helps to lower total serum triglycerides in healthy people. Omega 3 also helps to increase joint mobility as well as reduce inflammation and joint swelling associated with arthritis. They do not containAdded yeast starch gluten lactose sugar artificial flavours artificial sweeteners artificial colours artificial preservatives or dairy products. DosageAdults 2 capsules 3 times a day with food or as professionally prescribed. Children (age 6 to 12) 1 to 2 capsules daily with food or as professionally prescribed. Children (under 6) Consult your healthcare professional. Buy Vitamax Fish Oil and other Prescription Drugs 17 products online at Medstore. 5717
About Vitamax Fish Oil: Product Type: Prescription Drugs 17 Vitamax Fish Oil (Product Origin: New Zealand) Vitamax Fish Oil Vitamax Fish Oil 1000mg 440 Capsules Vitamax Fish Oil Vitamax Fish Oil
View more Prescription Drugs 17 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
